A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

被引:94
|
作者
Lu Gaohua [2 ]
Abduljalil, Khaled [2 ]
Jamei, Masoud [2 ]
Johnson, Trevor N. [2 ]
Rostami-Hodjegan, Amin [1 ,2 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England
[2] Simcyp Ltd, Sheffield, S Yorkshire, England
关键词
caffeine; metoprolol; midazolam; physiologically based pharmacokinetic model; pregnancy; BLOOD-BRAIN-BARRIER; TISSUE DISTRIBUTION; COMPUTER-MODEL; CAFFEINE; WOMEN; TRANSPORTERS; METOPROLOL; POSTPARTUM; SIMULATION; MIDAZOLAM;
D O I
10.1111/j.1365-2125.2012.04363.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Pregnant women are usually not part of the traditional drug development programme. Pregnancy is associated with major biological and physiological changes that alter the pharmacokinetics (PK) of drugs. Prediction of the changes to drug exposure in this group of patients may help to prevent under- or overtreatment. We have used a pregnancy physiologically based pharmacokinetic (p-PBPK) model to assess the likely impact of pregnancy on three model compounds, namely caffeine, metoprolol and midazolam, based on the knowledge of their disposition in nonpregnant women and information from in vitro studies. Methods A perfusion-limited form of a 13-compartment full-PBPK model (Simcyp (R) Simulator) was used for the nonpregnant women, and this was extended to the pregnant state by applying known changes to all model components (including the gestational related activity of specific cytochrome P450 enzymes) and through the addition of an extra compartment to represent the fetoplacental unit. The uterus and the mammary glands were grouped into the muscle compartment. The model was implemented in Matlab Simulink and validated using clinical observations. Results The p-PBPK model predicted the PK changes of three model compounds (namely caffeine, metoprolol and midazolam) for CYP1A2, CYP2D6 and CYP3A4 during pregnancy within twofold of observed values. The changes during the third trimester were predicted to be a 100% increase, a 30% decrease and a 35% decrease in the exposure of caffeine, metoprolol and midazolam, respectively, compared with the nonpregnant women. Conclusions In the absence of clinical data, the in silico prediction of PK behaviour during pregnancy can provide a valuable aid to dose adjustment in pregnant women. The performance of the model for drugs metabolized by a single enzyme to different degrees (high and low extraction) and for drugs that are eliminated by several different routes warrants further study.
引用
收藏
页码:873 / 885
页数:13
相关论文
共 50 条
  • [21] Investigation of cytochrome p450 CYP1A2, CYP2D6, CYP2E1 and CYP3A4 gene expressions and polymorphisms in alcohol with-drawal
    Tascioglu, Nazife
    Saatci, Cetin
    Emekli, Rabia
    Tuncel, Gulten
    Esel, Ertugrul
    Dundar, Munis
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2021, 24 (03): : 298 - 306
  • [22] 泰妙菌素对人CYP3A4、CYP1A2、CYP2E1、CYP2D6酶活性的影响
    陈芳
    高鸿
    李博
    左香溢
    靳珍
    汤有志
    中国畜牧兽医, 2020, 47 (04) : 1267 - 1273
  • [23] Suppression of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4/5 activity by a cocktail of inflammatory cytokines
    Foster, John
    Webber, Guy
    Ormsby, Terry
    Cheung, Yen-Ling
    Paul, Danny S.
    Webber, Colin
    Waring, Adrian
    DRUG METABOLISM REVIEWS, 2016, 48 : 89 - 89
  • [24] Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A.
    Kashuba, ADM
    Nafziger, AN
    Kearns, GL
    Leeder, JS
    Gotschall, R
    Rocci, ML
    Kulawy, RW
    Beck, DJ
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 153 - 153
  • [25] Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
    Tracy, TS
    Venkataramanan, R
    Glover, DD
    Caritis, SN
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (02) : 633 - 639
  • [26] Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin to related CYP2D6*10 allele
    Cho, Chang-Keun
    Kang, Pureum
    Park, Hye-Jung
    Lee, Yun Jeong
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (11) : 1037 - 1049
  • [27] Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia
    Iwahashi, K
    ACTA NEUROPSYCHIATRICA, 2004, 16 (04) : 229 - 230
  • [28] Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele
    Chang‑Keun Cho
    Pureum Kang
    Hye-Jung Park
    Yun Jeong Lee
    Jung‑Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Archives of Pharmacal Research, 2021, 44 : 1037 - 1049
  • [29] Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity
    Carrillo, JA
    Dahl, ML
    Svensson, JO
    Alm, C
    Rodriguez, I
    Bertilsson, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (02) : 183 - 190
  • [30] Comparison of Paeoniflorin and Albiflorin on Human CYP3A4 and CYP2D6
    Gao, Li-Na
    Zhang, Ye
    Cui, Yuan-Lu
    Akinyi, Olunga Mary
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015